Arnold Caplan, PhD from Case Western will serve as CSO. He was the founder of Osiris Therapeutics.
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology (BusinessWire)...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
